4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diol
4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diol Basic information
- Product Name:
- 4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diol
- Synonyms:
-
- CMS-121
- 1,2-Benzenediol,4-[4-(cyclopentyloxy)-2-quinolinyl]-
- 4-(4-(cyclopentyloxy)quinolin-2-yl)be nzene-1,2-diol (CMS121)
- ACC, Acetyl Coenzyme A Carboxylase,disease,neuroprotective,inhibit,anti-inflammatory,mitochondrial,Alzheimer's,antioxidative,acetylation,Inhibitor,H3K9,Acetyl-CoA Carboxylase,CMS 121,dementia,ACC1,CMS-121
- CMS-121, 10 mM in DMSO
- 4-(4-(cyclopentyloxy)quinolin-2-yl)be
- CAS:
- 1353224-53-9
- MF:
- C20H19NO3
- MW:
- 321.37
- Product Categories:
-
- CMS121
- Mol File:
- 1353224-53-9.mol
4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diol Chemical Properties
- Boiling point:
- 511.0±50.0 °C(Predicted)
- Density
- 1.297±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMF: 30 mg/ml; DMSO: 20 mg/ml
- form
- A crystalline solid
- pka
- 8.53±0.20(Predicted)
- color
- Light yellow to yellow
- InChI
- InChI=1S/C20H19NO3/c22-18-10-9-13(11-19(18)23)17-12-20(24-14-5-1-2-6-14)15-7-3-4-8-16(15)21-17/h3-4,7-12,14,22-23H,1-2,5-6H2
- InChIKey
- OMHNVUCFPJJLKD-UHFFFAOYSA-N
- SMILES
- C1(O)=CC=C(C2C=C(OC3CCCC3)C3C(N=2)=CC=CC=3)C=C1O
4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diol Usage And Synthesis
Uses
CMS-121 is a quinolone derivative and an orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor. CMS-121 protects HT22 cells against ischemia and oxidative damage with EC50 values of 7 nM and 200 nM, respectively. CMS-121 has strong neuroprotective, anti-inflammatory, antioxidative and renoprotective activities[1][2][3].
in vivo
CMS-121 (~20 mg/kg; oral administration; daily; for 4 months; female SAMP8 mice) treatment reduces cognitive decline as well as metabolic and transcriptional markers of aging in the brain when administered to rapidly aging SAMP8 mice. CMS-121 preserves mitochondrial homeostasis by regulating acetyl-coenzyme A (acetyl-CoA) metabolism[1].
| Animal Model: | Female SAMP8 mice (9 months old)[1] |
| Dosage: | ~20 mg/kg/day |
| Administration: | Oral administration; daily; for 4 months |
| Result: | Reduced cognitive decline as well as metabolic and transcriptional markers of aging in the brain. |
References
[1] Currais A, et al. Elevating acetyl-CoA levels reduces aspects of brain aging. Elife. 2019 Nov 19;8. pii: e47866. DOI:10.7554/eLife.47866
[2] Chiruta C, et al. Chemical modification of the multitarget neuroprotective compound fisetin. J Med Chem. 2012 Jan 12;55(1):378-89. DOI:10.1021/jm2012563
[3] Prior M, et al. Back to the future with phenotypic screening. ACS Chem Neurosci. 2014 Jul 16;5(7):503-13. DOI:10.1021/cn500051h
4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diolSupplier
- Tel
- 18270980682
- mlcheng@sunwaypharm.cn
- Tel
- 0086-512-6670 13382131678
- jc@mylandpharm.com
- Tel
- +86-021-58380978 13482386415
- info@systeambc.com
- Tel
- 13816613772
- huahero21@sina.com
- Tel
- 021-65675885 18964387627
- info@efebio.com